川芎嗪注射液、α-酮酸联合左旋氨氯地平治疗慢性肾功能衰竭的临床观察

摘要

OBJECTIVE:To observe the clinical efficacy and safety of Ligustrazine injection,α-ketoacid combined with levam-lodipine in the treatment of chronic renal failure. METHODS:92 patients with chronic renal failure were randomly divided into ob-servation group(46 cases)and control group(46 cases). All patients received electrolyte,vitamins and essential amino acid,low salt,low fat,hypoglycemic and hypolipemic,anti-infection,correcting anemia and other conventional symptomatic treatment. Based on it,control group received 8 Compound α-ketoacid tablets,3 times a day + 1 Benzenesulfonic acid levamlodipine tablet, once a day. Observation group additionally received 150 mg Ligustrazine hydrochloride injection,adding into 250 ml 5% Glucose injection,intravenous infusion,once a day. The treatment course for both groups was 3 months. Clinical efficacy,and urea nitro-gen (BUN),serum creatinine (Scr),serum cystatin (CysC),low-density lipoprotein cholesterol (LDL-C),total cholesterol (TC),triglyceride (TG) levels before and after treatment and the incidence of adverse reactions in 2 groups were observed. RE-SULTS:The total effective rate in observation group was significantly higher than control group,the difference was statistically sig-nificant(P<0.05). Before treatment,there were no significant differences in the BUN,Scr,CysC,LDL-C,TC and TG between 2 groups(P>0.05). After treatment,BUN,Scr,LDL-C,TC and TG in 2 groups were significantly lower than before,and obser-vation group was lower than control group,CysC was significantly higher than before,and observation group was higher than con-trol group,the differences were statistically significant (P<0.05). And there was no significant difference in the incidence of ad-verse reactions(P>0.05). CONCLUSIONS:Based on conventional treatment,Ligustrazine injection,α-ketoacid combined with le-vamlodipine show obvious efficacy in the treatment of chronic renal failure,they can improve the renal functions,with good safety.%目的：观察川芎嗪注射液、α-酮酸联合左旋氨氯地平治疗慢性肾功能衰竭的疗效和安全性。方法：92例慢性肾功能衰竭患者随机分为观察组（46例）和对照组（46例）。所有患者均给予电解质、维生素及氨基酸、低盐低脂、降糖降脂、抗感染及纠正贫血等常规对症治疗。在此基础上，对照组患者口服复方α-酮酸片8片，每日3次+苯磺酸左旋氨氯地平片1片，每日1次。观察组患者在对照组治疗的基础上给予盐酸川穹嗪注射液150 mg，加入5％葡萄糖250 ml中，静脉滴注，每日1次。两组疗程均为3个月。观察两组患者的临床疗效，治疗前后尿素氮（BUN）、血肌酐（Scr）、血清胱抑素（CysC）、低密度脂蛋白胆固醇（LDL-C）、总胆固醇（TC）、三酰甘油（TG）水平及不良反应发生情况。结果：观察组患者总有效率显著高于对照组，差异有统计学意义（P＜0.05）。治疗前，两组患者BUN、Scr、CysC、LDL-C、TC、TG比较，差异均无统计学意义（P＞0.05）。治疗后，两组患者BUN、Scr、LDL-C、TC、TG均显著低于同组治疗前，且观察组低于对照组，CysC显著高于同组治疗前，且观察组高于对照组，差异均有统计学意义（P＜0.05）。两组患者不良反应发生率比较，差异无统计学意义（P＞0.05）。结论：在常规治疗的基础上，川芎嗪注射液、α-酮酸联合左旋氨氯地平治疗慢性肾功能衰竭的疗效显著，可改善肾功能，且安全性较好。